medicine & medical supplies
supplies
. However, the Company does not require to seek approval from shareholders on this issue. 4. Total Asset and Investment Hospital building, medical equipment, medical supplies, in amount of Baht 133,583,482
. However, the Company does not require to seek approval from shareholders on this issue. 4. Total Asset and Investment Hospital building, medical equipment, medical supplies, in amount of Baht 133,583,482
every finished product and crude oil price crack spreads, with supporting factors ranging from the maintenance of various refineries in North Asia, as well as concerns over supplies tightening after the
for the raw materials procurement process issue. Nevertheless, the company was able to realized net profit excluding extraordinary item for FY2018 of THB 487 million, decreased by 7% from previous year
from CPO’s prices fluctuation. - Raw materials and By-product’s Quantity sold in the 3rd quarter of 2019 has contributed to 5.79% of total sales volume and 3.00% to total sales. Quantity sold decreased
was exporting new time high because the global price is higher than domestic. In addition, the price of raw materials abroad is higher than in local. However, the Company aware of the price fluctuation
a significant reduction in production. In addition, the domestic market has limited availability of refined glycerine as raw materials from biodiesel production have decreased in accordance with the
shortage of refined glycerine in the market, resulting in a significant reduction in production. In addition, the domestic market has limited availability of refined glycerine as raw materials from biodiesel